Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics Stock is Worth a Flier Before Earnings
02:22pm, Tuesday, 13'th Jul 2021
Quest Diagnostics Incorporated (NYSE:DGX) offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, and drugs.
TAMPA, Fla., July 12, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services today announced the Tackle Your Testing program t
Quest Diagnostics To Release Second Quarter 2021 Financial Results On July 22
09:31am, Tuesday, 06'th Jul 2021
SECAUCUS, N.J., July 6, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter
ProPhase Labs Is A Potential Pure Play On Worries About The Delta And Delta Plus Covid-19 Variants
02:18pm, Monday, 28'th Jun 2021
ProPhase Labs Is A Potential Pure Play On Worries About The Delta And Delta Plus Covid-19 Variants
Quest Diagnostics (DGX) Unveils Corporate Responsibility Report
10:32am, Wednesday, 23'rd Jun 2021
Per Quest Diagnostics' (DGX) 2020 Corporate Responsibility Report, it has expanded COVID-19 capacity throughout the year, performing 30 million COVID-19 molecular tests and serology tests.
Biocept partners with Quest Diagnostics to provide its Target Selector NGS-based liquid biopsy testing for lung cancer
09:32am, Tuesday, 22'nd Jun 2021
Biocept Inc (NASDAQ:BIOC) (FRA:B003) has announced a collaboration with Quest Diagnostics Inc (NYSE:DGX) (FRA:QDI) to provide laboratory testing services to Quest patients for its Target Selector NGS
Quest Diagnostics Releases Annual Corporate Responsibility Report
06:45am, Monday, 21'st Jun 2021
SECAUCUS, N.J., June 21, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released the Annual Corporate Responsi
2 Incredibly Cheap Healthcare Stocks
06:20am, Friday, 18'th Jun 2021
These companies dominate a vital medical industry niche, and their valuations are near their all-time lows.
3 Medical Diagnostics Stocks in Focus on Long-Term Potential
08:17am, Monday, 07'th Jun 2021
MedTech testing stocks like Quest Diagnostics Incorporated (DGX), Thermo Fisher Scientific, Inc. (TMO) and Laboratory Corporation of America Holdings (LH) are likely to survive post-pandemic.
3 Medical Info System Stocks to Bank on Despite Decline in COVID-19 Cases
12:48pm, Friday, 04'th Jun 2021
3 Medical Info System Stocks to Bank on Despite Decline in COVID-19 Cases
Quest Diagnostics: A Demographic Play At A Reasonable Price
07:36am, Thursday, 03'rd Jun 2021
Quest Diagnostics was one of the clear beneficiaries of the pandemic.
Quest Diagnostics (DGX) Buys Outreach Lab, Widens Midwest Base
09:47am, Wednesday, 02'nd Jun 2021
Mercy's outreach laboratory services are set to get integrated into Quest Diagnostics' (DGX) full-service laboratory in Lenexa, KS.
Quest Diagnostics Completes Acquisition of Mercy's Outreach Laboratory Services Business
04:05pm, Tuesday, 01'st Jun 2021
SECAUCUS, N.J. and ST. LOUIS, June 1, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX) and Mercy today announced that Quest has completed its previously announced acquisition of the outreach laborat
SECAUCUS, N.J., May 26, 2021 /PRNewswire/ -- The COVID-19 pandemic did not dampen workforce drug testing positivity for marijuana, which continued to increase last year in the general U.S. workforce,
Laboratory Corp: A Solid Margin of Safety
02:56pm, Tuesday, 25'th May 2021
Like many other diagnostics and drug development companies, Laboratory Corp. of America Holdings ( LH , Financial) saw its base business decline as Covid-19 took hold. Fewer patients sought routine me
